The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Toxoplasmosis, Congenital

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Toxoplasmosis, Congenital


High impact information on Toxoplasmosis, Congenital


Chemical compound and disease context of Toxoplasmosis, Congenital


Biological context of Toxoplasmosis, Congenital


Anatomical context of Toxoplasmosis, Congenital


Gene context of Toxoplasmosis, Congenital


Analytical, diagnostic and therapeutic context of Toxoplasmosis, Congenital


  1. Method for differentiation of nonspecific from specfic toxoplasma IgM fluorescent antibodies in patients with rheumatoid factor. Hyde, B., Barnett, E.V., Remington, J.S. Proc. Soc. Exp. Biol. Med. (1975) [Pubmed]
  2. Cholestatic jaundice due to congenital Toxoplasma gondii infection. Singh, S., Lodha, R., Passi, G.R., Bhan, M.K. Indian journal of pediatrics. (1998) [Pubmed]
  3. What is known about the prevention of congenital toxoplasmosis? Jeannel, D., Costagliola, D., Niel, G., Hubert, B., Danis, M. Lancet (1990) [Pubmed]
  4. Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Abou-Bacar, A., Pfaff, A.W., Georges, S., Letscher-Bru, V., Filisetti, D., Villard, O., Antoni, E., Klein, J.P., Candolfi, E. Infect. Immun. (2004) [Pubmed]
  5. Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis. Corvaisier, S., Charpiat, B., Mounier, C., Wallon, M., Leboucher, G., Al Kurdi, M., Chaulet, J.F., Peyron, F. Antimicrob. Agents Chemother. (2004) [Pubmed]
  6. Automated time-resolved immunofluorometric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130,000 filter-paper blood-spot samples from newborns. Sørensen, T., Spenter, J., Jaliashvili, I., Christiansen, M., Nørgaard-Pedersen, B., Petersen, E. Clin. Chem. (2002) [Pubmed]
  7. Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group. McLeod, R., Mack, D., Foss, R., Boyer, K., Withers, S., Levin, S., Hubbell, J. Antimicrob. Agents Chemother. (1992) [Pubmed]
  8. Neurologic and developmental outcome in treated congenital toxoplasmosis. Roizen, N., Swisher, C.N., Stein, M.A., Hopkins, J., Boyer, K.M., Holfels, E., Mets, M.B., Stein, L., Patel, D., Meier, P. Pediatrics (1995) [Pubmed]
  9. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. Trenque, T., Simon, N., Villena, I., Chemla, C., Quereux, C., Leroux, B., Jaussaud, R., Rémy, G., Dupouy, D., Millart, H., Pinon, J.M., Urien, S. British journal of clinical pharmacology. (2004) [Pubmed]
  10. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Villena, I., Aubert, D., Leroux, B., Dupouy, D., Talmud, M., Chemla, C., Trenque, T., Schmit, G., Quereux, C., Guenounou, M., Pluot, M., Bonhomme, A., Pinon, J.M. Scand. J. Infect. Dis. (1998) [Pubmed]
  11. Fitness of Toxoplasma gondii is not related to DHFR single-nucleotide polymorphism during congenital toxoplasmosis. Peyron, F., Eudes, N., de Monbrison, F., Wallon, M., Picot, S. Int. J. Parasitol. (2004) [Pubmed]
  12. HLA-class II genes modify outcome of Toxoplasma gondii infection. Mack, D.G., Johnson, J.J., Roberts, F., Roberts, C.W., Estes, R.G., David, C., Grumet, F.C., McLeod, R. Int. J. Parasitol. (1999) [Pubmed]
  13. Kinetics study of the localization and quantitation of target antigens of immunoglobulin a antibodies in acquired and congenital toxoplasmosis. Kumolosasi, E., Bonhomme, A., Beorchia, A., Foudrinier, F., Marx, C., Pluot, M., Pinon, J.M. Parasitol. Res. (1996) [Pubmed]
  14. Bax-induced apoptosis not demonstrated in the congenital toxoplasmosis in mice. Takahashi, J., Fukuda, T., Tanaka, J., Minamitani, M., Onouchi, K., Makioka, A. Brain Dev. (2001) [Pubmed]
  15. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Petersen, E., Schmidt, D.R. Expert review of anti-infective therapy. (2003) [Pubmed]
  16. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. Grover, C.M., Thulliez, P., Remington, J.S., Boothroyd, J.C. J. Clin. Microbiol. (1990) [Pubmed]
  17. Role of gamma interferon and T cells in congenital Toxoplasma transmission. Abou-Bacar, A., Pfaff, A.W., Letscher-Bru, V., Filisetti, D., Rajapakse, R., Antoni, E., Villard, O., Klein, J.P., Candolfi, E. Parasite Immunol. (2004) [Pubmed]
  18. The role of IL-4 in adult acquired and congenital toxoplasmosis. Alexander, J., Jebbari, H., Bluethmann, H., Brombacher, F., Roberts, C.W. Int. J. Parasitol. (1998) [Pubmed]
  19. A switch towards Th2 during serological rebound in children with congenital toxoplasmosis. Kahi, S., Cozon, G.J., Pinon, J.M., Greenland, T., Wallon, M., Al Kurdi, M., Ferrandiz, J., Peyron, F. Clin. Exp. Immunol. (1999) [Pubmed]
  20. Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts. Fatoohi, A.F., Cozon, G.J., Wallon, M., Kahi, S., Gay-Andrieu, F., Greenland, T., Peyron, F. Eur. J. Clin. Microbiol. Infect. Dis. (2003) [Pubmed]
  21. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. Yamamoto, J.H., Vallochi, A.L., Silveira, C., Filho, J.K., Nussenblatt, R.B., Cunha-Neto, E., Gazzinelli, R.T., Belfort, R., Rizzo, L.V. J. Infect. Dis. (2000) [Pubmed]
  22. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. Naot, Y., Desmonts, G., Remington, J.S. J. Pediatr. (1981) [Pubmed]
  23. Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis. Foudrinier, F., Villena, I., Jaussaud, R., Aubert, D., Chemla, C., Martinot, F., Pinon, J.M. J. Clin. Microbiol. (2003) [Pubmed]
  24. Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin g profiles. Nielsen, H.V., Schmidt, D.R., Petersen, E. J. Clin. Microbiol. (2005) [Pubmed]
WikiGenes - Universities